Genes to Cells · 2009 · 61 citations · 29 references
Life SciencesCell BiologyMolecular BiologyCell SignalingOncogenesSignal TransductionBone Morphogenetic Protein SignalingGrowth Factor SignalingReceptor-mediated SignalingBmp Signal TransductionBone Morphogenetic Protein ReceptorsPlasminogen ActivatorsReceptorsSmad Signaling PathwayTransforming Growth Factor Beta Receptor SignalingTransforming Growth Factor Beta ReceptorsTransforming Growth Factor-beta Signaling
In current models of transforming growth factor-beta (TGF-beta) family signaling, type II receptors activate specific activin receptor-like kinase (ALK) type I receptors. These serine/threonine kinases activate ligand-dependent receptor regulated (R)-Smad by phosphorylating carboxy-terminal serines. We found that the receptor expression levels affected the phosphorylation and activation of the two R-Smad subclasses, activin/TGF-beta-specific (AR-Smad) and bone morphogenetic protein (BMP)-specific (BR-Smad). Co-expressing constitutively active type I and type II receptors in COS7 cells resulted in the phosphorylation of both R-Smad subclasses in a ligand-independent manner. This was verified using in vitro kinase assays. In untransfected B16 melanoma cells, TGF-beta1 and BMP-2 induced phosphorylation of both R-Smad subclasses, and TGF-beta1 up-regulated the inhibitor of differentiation (Id) gene, which is usually regulated by BMP. By contrast, BMP-2 up-regulated plasminogen activator inhibitor-1 (PAI-1), which is an AR-Smad-regulated gene. Except for ALK4 and ALK6, levels of type I and type II receptor mRNAs were higher in B16 cells than in HeLa and HepG2 cells, in which TGF-beta1 and BMP-2 induced phosphorylation of only the expected R-Smad. These results help to explain the diverse effects of this ligand family.
29
Gareth J. Inman, Francisco José Nicolás, James F. Callahan et al. · Molecular Pharmacology · 2002 · 1.7K citations
Olexandr Korchynskyi, Peter ten Dijke · Journal of Biological Chemistry · 2002 · 882 citations · Full text